Primary Care in AURA for COVID-19

Completed

• Conditions: COVID-19 Pandemic; Primary Care : Suspected and Confirmed Cases of COVID-19; Primary Health Care
• Interventions: Other: No intervention (surveillance system)

• Registration Number: NCT05124145
• Lead Sponsor: Research on Healthcare Performance Lab U1290

Brief Summary

As few data are available on the epidemiology of the COVID-19 in primary care, the project aims to implement a practice-based surveillance network based on multiprofessional health homes in the French region Auvergne-Rhône-Alpes (Aura), able to monitor the evolution of the current epidemic.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-01
• Primary Completion: 2020-11-02
• Status Verified: 2021-11
• Study Completion: 2021-11-05
• Study First Submitted: 2021-11-16
• Study First Submitted QC: 2021-11-16
• Study First Posted: 2021-11-17
• Last Update Submitted: 2021-11-17
• Last Update Posted: 2021-11-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 7000

Inclusion Criteria

• Suspect or confirmed COVID-19 case consulting in primary care in the Aura region

Exclusion Criteria

• Patient with a COVID-19 diagnosis excluded after clinical examination or investigation.
• Patient refusing to participate to the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
surveillance network	No intervention (surveillance system)	The surveillance network is made of 200 health professionals from 85 practices

Primary Outcome Measures

Name	Time	Method
Estimation of the weekly incidence of COVID-19 confirmed cases	30 days after the COVID-19 suspected	Confirmed cases will be defined by the positivity of the detection of SARS-CoV-2 in RT-PCR and possibly by serology (for patients in whom a test is performed).; The incidence rate of confirmed cases will be estimated from the number of new cases confirmed by a positive biological test reported in the patient population of the participating facilities.

Trial Locations

Locations (1)

RESHAPE; 🇫🇷 Lyon, France